Atopic Dermatitis (AD) Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
Atopic Dermatitis (AD)
Chengdu Kangnuoxing Biopharma,Inc.1,000 enrolled1 locationNCT07544862
Recruiting
Phase 2
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
Atopic Dermatitis (AD)
Keymed Biosciences Co.Ltd246 enrolled1 locationNCT07230483